Skip to main content
. 2020 Jan 6;94(2):e01632-19. doi: 10.1128/JVI.01632-19

FIG 5.

FIG 5

Frequency of cross-reactive responses increased over homologous sequential MRKAd5 vaccination (n = 13). (A) Net response magnitudes following the 2nd and 3rd vaccinations to vaccine or variant epitopes (mixed-effect model). (B) Response depth per vaccinee to variant epitopes at these time points (Wilcoxon signed-rank test).